10E8.4/iMab (Aaron Diamond AIDS Research Center)

N/A

Report date: 2022/03/17 18:23:40

Base Information

Drug Name10E8.4/iMab (Aaron Diamond AIDS Research Center)

Drug Alias NameTMB-Bispecific10E8.4/iMab Bispecific AntibodyTMB Bispecific(Taimed biologics)TMB-370

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-CD4Viral fusion proteins inhibitors

TargetsT-cell surface antigen CD4Viral fusion proteins

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAaron Diamond Aids Research Center For The City Of New York, Inc

China Registration ClassN/A

Develop Information

Active CompaniesTaimed Biologics Inc

Inactive CompaniesN/A

Active IndicationsHIV Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A